Dashboard
Manage Tickers

CNMDCONMED Corp

NYSE conmed.com


$ 71.34 $ 0.17 (0.24 %)    

Wednesday, 04-Sep-2024 15:59:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 460.65 $ -1.20 (-0.26 %)
DIA $ 410.44 $ 0.17 (0.04 %)
SPY $ 550.83 $ -1.13 (-0.2 %)
TLT $ 98.96 $ 1.26 (1.29 %)
GLD $ 230.43 $ 0.14 (0.06 %)
$ 71.33
$ 71.17
$ 71.44 x 100
$ 71.25 x 100
$ 71.14 - $ 73.33
$ 60.88 - $ 116.47
228,681
na
2.2B
$ 1.58
$ 22.30
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 04-25-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 10-26-2023 09-30-2023 10-Q
5 07-27-2023 06-30-2023 10-Q
6 04-27-2023 03-31-2023 10-Q
7 02-21-2023 12-31-2022 10-K
8 10-27-2022 09-30-2022 10-Q
9 07-28-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 02-22-2022 12-31-2021 10-K
12 10-28-2021 09-30-2021 10-Q
13 07-29-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 02-22-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 07-30-2020 06-30-2020 10-Q
18 04-30-2020 03-31-2020 10-Q
19 02-24-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 04-26-2019 03-31-2019 10-Q
23 02-25-2019 12-31-2018 10-K
24 11-02-2018 09-30-2018 10-Q
25 08-02-2018 06-30-2018 10-Q
26 04-26-2018 03-31-2018 10-Q
27 02-26-2018 12-31-2017 10-K
28 11-02-2017 09-30-2017 10-Q
29 07-27-2017 06-30-2017 10-Q
30 04-27-2017 03-31-2017 10-Q
31 02-27-2017 12-31-2016 10-K
32 10-28-2016 09-30-2016 10-Q
33 07-28-2016 06-30-2016 10-Q
34 05-02-2016 03-31-2016 10-Q
35 02-23-2016 12-31-2015 10-K
36 10-23-2015 09-30-2015 10-Q
37 07-27-2015 06-30-2015 10-Q
38 04-24-2015 03-31-2015 10-Q
39 02-23-2015 12-31-2014 10-K
40 10-24-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

peeling-back-the-layers-exploring-conmed-through-analyst-insights
Peeling Back The Layers: Exploring Conmed ...
08/01/2024 17:04:41

piper-sandler-maintains-overweight-on-conmed-lowers-price-target-to-80
Piper Sandler Maintains Overweight on Conm...
08/01/2024 15:50:40

Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $95 t...

stifel-maintains-buy-on-conmed-lowers-price-target-to-76
Stifel Maintains Buy on Conmed, Lowers Pri...
08/01/2024 14:31:03

Stifel analyst Rick Wise maintains Conmed (NYSE:CNMD) with a Buy and lowers the price target from $88 to $76.

wells-fargo-maintains-equal-weight-on-conmed-lowers-price-target-to-71
Wells Fargo Maintains Equal-Weight on Conm...
08/01/2024 14:03:15

Wells Fargo analyst Vik Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $77 to $71.

needham-maintains-buy-on-conmed-lowers-price-target-to-97
Needham Maintains Buy on Conmed, Lowers Pr...
08/01/2024 09:46:55

Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and lowers the price target from $106 to $97.

conmed-corporation-sees-fy24-adj-eps--395-402-vs-prior-range-of-425-435-revenue-1305b-1315b-vs-prior-range-of-133b-1355b
CONMED Corporation Sees FY24 Adj. EPS $3....
07/31/2024 21:27:52

conmed-q2-2024-adj-eps-098-beats-091-estimate-sales-332097m-miss-332325m-estimate
Conmed Q2 2024 Adj. EPS $0.98 Beats $0.91 ...
07/31/2024 21:04:24

Conmed (NYSE:CNMD) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.91 by 7.69 pe...

needham-maintains-buy-on-conmed-lowers-price-target-to-106
Needham Maintains Buy on Conmed, Lowers Pr...
07/25/2024 09:46:02

Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and lowers the price target from $107 to $106.

needham-reiterates-buy-on-conmed-maintains-107-price-target
Needham Reiterates Buy on Conmed, Maintain...
05/06/2024 09:49:36

Needham analyst Mike Matson reiterates Conmed (NYSE:CNMD) with a Buy and maintains $107 price target.

1m-bet-on-skyworks-solutions-check-out-these-3-stocks-insiders-are-buying
$1M Bet On Skyworks Solutions? Check Out T...
05/03/2024 13:02:56

jp-morgan-maintains-overweight-on-conmed-lowers-price-target-to-75
JP Morgan Maintains Overweight on Conmed, ...
04/25/2024 17:38:22

JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $115 to $75.

wells-fargo-maintains-equal-weight-on-conmed-lowers-price-target-to-77
Wells Fargo Maintains Equal-Weight on Conm...
04/25/2024 14:21:25

Wells Fargo analyst Vik Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $98 to $77.

piper-sandler-maintains-overweight-on-conmed-lowers-price-target-to-95
Piper Sandler Maintains Overweight on Conm...
04/25/2024 12:51:57

Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $100 ...

analyst-scoreboard-5-ratings-for-conmed
Analyst Scoreboard: 5 Ratings For Conmed
04/25/2024 12:01:45

needham-maintains-buy-on-conmed-lowers-price-target-to-107
Needham Maintains Buy on Conmed, Lowers Pr...
04/25/2024 09:55:16

Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and lowers the price target from $129 to $107.

conmed-corporation-promotes-patrick-beyer-to-chief-operating-officer-effective-immediately
CONMED Corporation Promotes Patrick Beyer ...
04/24/2024 20:58:10

CONMED Corporation (NYSE:CNMD) today announced that Patrick Beyer, President of International and Global Orthopedics, has been ...

conmed-sees-fy24-adj-eps-425-435-vs-433-est-revenue-1330b-1355b-vs-1350b-est
CONMED Sees FY24 Adj. EPS $4.25-$4.35 Vs $...
04/24/2024 20:42:17

conmed-q1-2024-adj-eps-079-beats-074-estimate-sales-312273m-beat-306776m-estimate
Conmed Q1 2024 Adj EPS $0.79 Beats $0.74 E...
04/24/2024 20:11:38

Conmed (NYSE:CNMD) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.74 by 6.76 pe...

cracking-the-code-understanding-analyst-reviews-for-conmed
Cracking The Code: Understanding Analyst R...
02/01/2024 21:00:36

piper-sandler-maintains-overweight-on-conmed-lowers-price-target-to-100-report-released-on-31-january-2024
Piper Sandler Maintains Overweight on Conm...
02/01/2024 20:18:48

Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $130 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION